Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity
Open Access
- 30 July 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 127 (4), 466-482
- https://doi.org/10.1161/CIRCRESAHA.119.316463
Abstract
Rationale: Endothelial cells (ECs) are highly glycolytic and generate the majority of their energy via the breakdown of glucose to lactate. At the same time, a main role of ECs is to allow the transport of glucose to the surrounding tissues. GLUT1 (glucose transporter isoform 1/Slc2a1) is highly expressed in ECs of the central nervous system (CNS) and is often implicated in blood-brain barrier (BBB) dysfunction, but whether and how GLUT1 controls EC metabolism and function is poorly understood. Objective: We evaluated the role of GLUT1 in endothelial metabolism and function during postnatal CNS development as well as at the adult BBB. Methods and Results: Inhibition of GLUT1 decreases EC glucose uptake and glycolysis, leading to energy depletion and the activation of the cellular energy sensor AMPK (AMP-activated protein kinase), and decreases EC proliferation without affecting migration. Deletion of GLUT1 from the developing postnatal retinal endothelium reduces retinal EC proliferation and lowers vascular outgrowth, without affecting the number of tip cells. In contrast, in the brain, we observed a lower number of tip cells in addition to reduced brain EC proliferation, indicating that within the CNS, organotypic differences in EC metabolism exist. Interestingly, when ECs become quiescent, endothelial glycolysis is repressed, and GLUT1 expression increases in a Notch-dependent fashion. GLUT1 deletion from quiescent adult ECs leads to severe seizures, accompanied by neuronal loss and CNS inflammation. Strikingly, this does not coincide with BBB leakiness, altered expression of genes crucial for BBB barrier functioning nor reduced vascular function. Instead, we found a selective activation of inflammatory and extracellular matrix related gene sets. Conclusions: GLUT1 is the main glucose transporter in ECs and becomes uncoupled from glycolysis during quiescence in a Notch-dependent manner. It is crucial for developmental CNS angiogenesis and adult CNS homeostasis but does not affect BBB barrier function.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (11V1915N)
- Stichting Tegen Kanker
- EC | European Research Council
- Krebsforschung Schweiz
- Jubiläumsstiftung der Schweizerischen Lebensversicherungs- und Rentenanstalt für Volksgesundheit und medizinische Forschung
This publication has 52 references indexed in Scilit:
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In VivoPLOS ONE, 2011
- Fecal Microbiota in Premature Infants Prior to Necrotizing EnterocolitisPLOS ONE, 2011
- Acute Modulation of Sugar Transport in Brain Capillary Endothelial Cell Cultures during Activation of the Metabolic Stress PathwayPublished by Elsevier BV ,2010
- Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesisProceedings of the National Academy of Sciences, 2009
- A role for leukocyte-endothelial adhesion mechanisms in epilepsyNature Medicine, 2008
- KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endotheliumBlood, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer DiseaseJournal of Neurochemistry, 1989
- Glycogen metabolism in the capillary endothelium: Electron histochemical study of glycogen synthetase and phosphorylase in the pecten capillary of the chickActa Histochemica, 1983